Depression in Parkinson's disease

Acta Psychiatrica Scandinavica

Volumn 106, Issue 3, 2002, Pages 161-162

  Aarsland, Dag ^a   Cummings, Jeffrey L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGING; AKINESIA; CLINICAL FEATURE; COGNITIVE DEFECT; DEMOGRAPHY; DEPRESSION; EDITORIAL; FAMILY HISTORY; HOSPITALIZATION; HUMAN; MESOLIMBIC DOPAMINERGIC SYSTEM; ONSET AGE; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEROTONINERGIC SYSTEM;

DEPRESSIVE DISORDER; HUMANS; PARKINSON DISEASE; RISK FACTORS;

EID: 0036736506     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0447.2002.2e009.x     Document Type: Editorial

References (14)

1. TANDBERG E, LARSEN JP, NESSLER EG, RIISE T, AARLI JA. The epidemiology of Parkinson' disease in the country of Rogaland, Norway. Mov Disord 1995;10:541-549.
2. WINKER M. Aging in the 21st century. JAMA 2002;287:1326.
3. AARSLAND D, LARSEN JP, LIM NG et al. Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999:67:492-496.
4. KARLSEN K, TANDBERG E, ÅRSLAND D, LARSEN JP. Health related quality of health in Parkinson's disease: a prospective longitudinal study. J Neurol Neurosurg Psychiatry 2000;69:584-589.
5. AARSLAND LARSEN JP, KARLSEN K, LIM NG, TANDBERG E. Mental symptoms in Parkinson's disease are important contributors to caregiver distress. Int J Geriatr Psychiatry 1999;14:866-874.
6. MAYEUX R, STERN Y, COTE L, WILLIAMS JBW. Altered serotonin metabolism in depressed patients with Parkinson's disease. Neurology 1984;34:642-646.
7. REMY P, DODED M, LEES AJN TURJANSKI N, HAMMERS A, BROOKS DJ. Depression in Parkinson's disease is associated with impaired catecholamine terminal function in the midbrain, thalamus and anterior cingulate cortex. Neurology 2002;58(Suppl. 3):A488.
8. CUMMINGS JL. Depression in Parkinson's disease: a review. Am J Psychiatry 1992;149:443-454.
9. NILSSON FM, KESSING LV, MØLLER SØRENSEN T, KRAGH-ANDERSEN T, BOLWIG TG. Major depressive disorder in Parkinson's disease: a register-based study. Acta Psychiatr Scand 2002;106:202-211.
10. LEENTJENS AFG, LOUSBERG R, VERHEY FRJ. Markers for depression in Parkinson's disease. Acta Psychiatr Scand 2002;106:196-201.
11. NILSSON FM, KESSING LV, BOLWIG TG. Increased risk of developing Parkinson's disease for patients with major affective disorders. Acta Psychiatr Scand 2001;104:380-386.
12. GONERA EG, VANT'HOF M, BERGER HJC, VAN WEEL C, HORSTINK MWIM. Symptoms and duration of the prodromal phase in Parkinson's disease. Mov Disord 1997;12:871-876.
13. ROBINSON RG, KUBOS KL, STARR LB, RAO K, PRICE TR. Mood disorders in stroke patients: importance of location of lesion. Brain 1984;107:81-93.
14. BAXTER LR, SCHWARTZ JC, MAZZIOTTA JC et al. Reduction of prefrontal cortical glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989;46:243-250.